drugset / Trial / NCT04267276
A Study in Healthy Men to Test How BI 1265162 is Taken up and Processed by the Body
Non-randomizedSingle-groupOpen-labelBasic science
Summary
To investigate rates and routes of excretion, mass balance, pharmacokinetics of parent drug, any known metabolites, and total radioactivity, metabolite profiling, metabolite identification, if suitable assays are available, safety and tolerability in healthy male subjects.
Timeline
- Start
- 2020-02-18
- Primary completion
- 2020-04-02
- Completion
- 2020-04-02
Outcome
Outcome not reported
Stopped (Enrollment): “Due to the COVID-19 pandemic, the recruitment of new subjects was temporarily halted in March 2020. The study was permanently discontinued in December 2020.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1265162 | Unknown | — | Intravenous |
Indications
No indication recorded.